Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / News / 2011 News / UNC Lineberger Genetics Policy, Law, Medicine Expert Discusses March 29, 2010 US District Court Gene Patenting Ruling

UNC Lineberger Genetics Policy, Law, Medicine Expert Discusses March 29, 2010 US District Court Gene Patenting Ruling

by Susan Lucas last modified Apr 01, 2011 01:43 PM
UNC Lineberger Genetics Policy, Law, Medicine Expert Discusses March 29, 2010 US District Court Gene Patenting Ruling

Dr. Jim Evans

CHAPEL HILL, NC - Dr. Jim Evans is an expert in gene patenting and genetics policy who has led a program to educate federal judges about the intricacies of genetics and genetic policy as well as chairing a Federal task force that looked into the issue of gene patents. That task force, part of the Secretary's Advisory Committee on Genetics, Health and Society, recently made formal recommendations to the Secretary of HHS regarding the role of gene patents in medical diagnostics. Dr. Evans says the March 29, 2010 ruling by United States District Court Judge Robert Sweet that invalidated seven patents related to the BRCA 1 and BRCA 2 genes "came as a surprise to everybody. It's really quite unusual for plaintiffs to get a summary judgment."

Evans, who has advised the secretary of Health and Human Services, is a medical geneticist and holds medical and doctoral degrees. He is director of Clinical Cancer Genetics and is the Bryson Distinguished Chair of Human Genetics at UNC and a member of UNC Lineberger.

Watch video interview – part 1. An icon indicating that content may be viewed on YouTube (TM).
Watch video interview – part 2. An icon indicating that content may be viewed on YouTube (TM).